Home>Topics>Companies>Becton Dickinson

Becton Dickinson BDX

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. Headlines
    1. Becton , Dickinson And Company : A Sharp Investment


      Sat, 20 Sep 2014

      daily basis, Becton , Dickinson and Company (NYSE: BDX ). Company and Industry Overview : Becton , Dickinson and Company is a global medical ..... as 3 segments: BD Medical , BD Diagnostics ..... click to enlarge) BD Medical : This segment

    2. Antares Pharma: Significant Value Or Value Trap?


      Fri, 12 Sep 2014

      By Mark Chapman : It has now been about 6 months since I penned an article about Antares Pharma (NASDAQ: ATRS ) suggesting that Otrexup alone should make the stock worth $5.10. Considering that the stock market is forward looking, and not a single one of my potential catalysts came to fruition, I

    3. Medtronic: Benefits Of Covidien Acquisition Not Enough To Make It A Buy


      Wed, 10 Sep 2014

      By Dividends4Life : Linked here is a detailed quantitative analysis of Medtronic Inc. (NYSE: MDT ). Below are some highlights from the above linked analysis: Company Description: Medtronic Inc. is a global medical device manufacturer has leadership positions in the pacemaker, defibrillator, ...

    4. New Morningstar Analyst Report for Becton Dickinson & Co

      Stock Reports

      Mon, 8 Sep 2014

      disclosures are very detailed, and the company doesn't pollute its financial statements with non-GAAP adjustments. Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps

    5. Markman hearing today regarding Enzo Biochem patents


      Mon, 18 Aug 2014

      event in patent litigation. The company has outstanding patent disputes with Abbott Labs, Affymetrix, Agilent, Becton Dickinson , Gen-Probe, Hologic, Ilumina, Life Technologies, Luminex, Roche and Seimens. Post your comment!

    6. Becton Dickinson Reports Slightly Better-Than-Expected 3Q; Raising Our Fair Value Estimate


      Thu, 31 Jul 2014

      Becton Dickinson reported third-quarter results, and its year-to-date numbers ..... revenue growth came in at 4.6% on a constant-currency basis. BD Medical was up 4.7% on the currency-neutral basis, with med surge and

    7. Becton Dickinson Reports Uneventful 2Q; Maintaining Our Fair Value Estimate


      Thu, 1 May 2014

      Becton Dickinson reported second-quarter results and slightly raised its EPS guidance ..... revenue growth came in at 5.1% on a constant-currency basis. BD Medical delivered the strongest results with a 6% increase in revenue (partially

    8. Becton Dickinson BDX Q2 2014 Earnings Call Transcript


      Thu, 1 May 2014

      Hello, and welcome to BD's Second Fiscal Quarter 2014 Earnings Call. At the request of BD, today's call is being recorded. It will be available for replay through May 8, 2014, on the Investors page of the bd.com website or by phone at 800-585-8967 for domestic calls and area code 404-537-3406 for

    9. Becton Dickinson Boosts the Low End of its Fiscal 2014 Expectations


      Tue, 4 Feb 2014

      Becton Dickinson reported fiscal first-quarter results ..... of growth. Of the three segments, BD Medical delivered the strongest results with ..... unfavorable pricing, namely within BD Medical and BD Bioscience. The company now

    10. An Uneventful Fourth Quarter for Becton Dickinson


      Tue, 5 Nov 2013

      Becton Dickinson reported fiscal fourth-quarter results and provided its 2014 outlook ..... quarter, albeit aided by order timing and stimulus in Japan. Both BD Medical and BD Diagnostics were in line with expectations. We saw no surprises

    « Prev12345Next »
    Content Partners